Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series.

Abstract

Kratom (Mitragyna speciosa) and its active alkaloids mitragynine and 7-hydroxymitragynine (7-OH) demonstrate mu-opioid receptor activity. Purified 7-OH products produce disproportionately strong opioid effects compared with natural kratom, increasing the risk of dependence. Buprenorphine has been used to manage 7-OH withdrawal. This retrospective chart review describes buprenorphine initiation among patients with problematic 7-OH use. Successful initiation was associated with symptom improvement, supporting clinical approaches for this emerging substance use disorder.

Overview

Integrity signals

Registry

Crossref · 10.1097/adm.0000000000001723

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 19 references

Cited by

See all 2

Metadata

Authors
Fenske, E., Williams, B., Hallock-Koppelman, L., & Buchheit, B. M.
Affiliations
Oregon Health & Science University (US)
Venue
Journal of addiction medicine
Published
2026-06-01
ISSN
  • 1932-0620 (ISSN-L)
  • 1935-3227
OpenAlex
W7163082224
Cited by
2
References
19
Citations by year
2026: 2
FWCI
13.38
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Addiction Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
buprenorphine, 7-hydroxymitragynine, Mitragyna speciosa, opioid withdrawal, substance use disorders, initiation timing, dosing regimen, mu-opioid receptor agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series. https://app.cochat.ai/papers/10.1097/adm.0000000000001723
The paper
Fenske, E., Williams, B., Hallock-Koppelman, L., & Buchheit, B. M. (2026). Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001723

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.